Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Pain Therapeutics will soon launch a Phase 1 clinical trial to study the safety and efficacy of PTI-125 in treating Alzheimer’s disease. The announcement came after the U.S. Food and Drug Administration (FDA) accepted the ... Read more
A poor night’s sleep may increase the levels of proteins associated with Alzheimer’s disease, say researchers, noting that their findings may be especially important for people with chronic sleep disorders. ... Read more
An enzyme called asparagine endopeptidase contributes to Parkinson’s as well as Alzheimer’s by slicing off fragments of proteins that end up being toxic, a study reports. Previous researched showed that ... Read more
Alzheimer’s deaths in the United States have jumped more than 50 percent in 15 years, according to the Centers for Disease Control and Prevention. One reason for the increase is that physicians ... Read more
A high-fat, high-sugar diet may increase the risk of Alzheimer’s disease in people carrying the ApoE4 gene, according to a new study, “Obesity Accelerates Alzheimer-Related Pathology in APOE4 but Not APOE3 Mice,” ... Read more
Higher levels of a molecule called anthranilic acid could signal that a person is at increased risk of developing dementia and Alzheimer’s disease, according to a study. The research, “Association ... Read more
Acadia Pharmaceuticals plans to start a Phase 3 clinical program to explore the effect of Nuplazid (pimavanserin) in Alzheimer’s disease patients with psychosis. The medication was approved by the U.S. ... Read more